These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24998828)

  • 21. Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases.
    Sasaki N; Fukatsu R; Tsuzuki K; Hayashi Y; Yoshida T; Fujii N; Koike T; Wakayama I; Yanagihara R; Garruto R; Amano N; Makita Z
    Am J Pathol; 1998 Oct; 153(4):1149-55. PubMed ID: 9777946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Significance of tau in the development of Alzheimer's disease].
    Takashima A
    Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ibuprofen and lipoic acid codrug 1 control Alzheimer's disease progression by down-regulating protein kinase C ε-mediated metalloproteinase 2 and 9 levels in β-amyloid infused Alzheimer's disease rat model.
    Zara S; Rapino M; Sozio P; Di Stefano A; Nasuti C; Cataldi A
    Brain Res; 2011 Sep; 1412():79-87. PubMed ID: 21820649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent progress in the development of disease-modifying therapies for Alzheimer's disease].
    Abe K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2010 Feb; 30(1):1-8. PubMed ID: 20297736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis.
    Coria F; Castaño E; Prelli F; Larrondo-Lillo M; van Duinen S; Shelanski ML; Frangione B
    Lab Invest; 1988 Apr; 58(4):454-8. PubMed ID: 2965774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of novel proteins associated with secondary amyloidosis and Alzheimer's disease by monoclonal antibody.
    Yamashita T; Imai K; Saito N; Yachi A
    Brain Res; 1988 Dec; 474(2):309-15. PubMed ID: 3208135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failed Alzheimer's trial does not kill leading theory of disease.
    Abbott A; Dolgin E
    Nature; 2016 Nov; 540(7631):15-16. PubMed ID: 27905452
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebral Abeta amyloidosis and postmenopausal hormone deficiency: roles in the genesis of Alzheimer's disease.
    Gandy S
    Hum Pathol; 2004 Mar; 35(3):271-4. PubMed ID: 15017581
    [No Abstract]   [Full Text] [Related]  

  • 31. [A Review of Clinical Studies Investigating Patients with Alzheimer's Disease having Genetic Risk Factors].
    Tanaka T; Ikeda M
    Brain Nerve; 2017 Jul; 69(7):723-731. PubMed ID: 28739985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease.
    Tabaton M; Perry G; Zhu X; Lee HG; Casadesus G; Smith MA
    Am J Pathol; 2010 Feb; 176(2):540-1. PubMed ID: 20019185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease: The right drug, the right time.
    Golde TE; DeKosky ST; Galasko D
    Science; 2018 Dec; 362(6420):1250-1251. PubMed ID: 30545877
    [No Abstract]   [Full Text] [Related]  

  • 34. [Drug development for overcoming dementia in Japan].
    Nakamura H
    Rinsho Shinkeigaku; 2014; 54(12):1181-3. PubMed ID: 25672739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease.
    Pluta R
    Curr Neurovasc Res; 2004 Dec; 1(5):441-53. PubMed ID: 16181092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloidosis in Alzheimer's disease.
    Wisniewski T; Frangione B
    Lancet; 1995 Aug; 346(8972):441. PubMed ID: 7677907
    [No Abstract]   [Full Text] [Related]  

  • 37. Pathogenesis and disease-modifying therapy in Alzheimer's disease: the flat line of progress.
    Castellani RJ; Perry G
    Arch Med Res; 2012 Nov; 43(8):694-8. PubMed ID: 23085451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sporadic dementia of Alzheimer type: role of amyloid in etiology is challenged.
    Hoyer S
    J Neural Transm Park Dis Dement Sect; 1993; 6(3):159-65. PubMed ID: 8123189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacotherapy in Alzheimer's disease: basis and rationale.
    Narang PK; Cutler NR
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(3-5):519-31. PubMed ID: 3541049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease: clinical trials and the amyloid hypothesis.
    Cummings J
    Ann Acad Med Singap; 2011 Jul; 40(7):304-6. PubMed ID: 21870020
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.